Risk of evolutionary escape from neutralizing antibodies targeting SARS-CoV-2 spike protein
View ORCID ProfileDebra Van Egeren, View ORCID ProfileAlexander Novokhodko, View ORCID ProfileMadison Stoddard, Uyen Tran, Bruce Zetter, Michael Rogers, View ORCID ProfileBradley L. Pentelute, Jonathan M. Carlson, View ORCID ProfileMark Hixon, View ORCID ProfileDiane Joseph-McCarthy, View ORCID ProfileArijit Chakravarty
doi: https://doi.org/10.1101/2020.11.17.20233726
Debra Van Egeren
1Harvard Medical School, Boston, MA, USA
2Dana-Farber Cancer Institute, Boston, MA, USA
3Boston Children’s Hospital, Boston, MA, USA
Alexander Novokhodko
4University of Washington, Seattle, WA, USA
Madison Stoddard
5Fractal Therapeutics, Cambridge, MA, USA
Uyen Tran
5Fractal Therapeutics, Cambridge, MA, USA
Bruce Zetter
1Harvard Medical School, Boston, MA, USA
3Boston Children’s Hospital, Boston, MA, USA
Michael Rogers
1Harvard Medical School, Boston, MA, USA
3Boston Children’s Hospital, Boston, MA, USA
Bradley L. Pentelute
6Massachusetts Institute of Technology, Cambridge, MA, USA
Jonathan M. Carlson
7Microsoft Research, Redmond, WA, USA
Mark Hixon
8Mark S. Hixon Consulting, LLC, San Diego, CA, USA
Diane Joseph-McCarthy
9Boston University, Boston, MA, USA
Arijit Chakravarty
5Fractal Therapeutics, Cambridge, MA, USA
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data used in the manuscript is publicly available, through the GISAID database or the cited references.
Posted December 11, 2020.
Risk of evolutionary escape from neutralizing antibodies targeting SARS-CoV-2 spike protein
Debra Van Egeren, Alexander Novokhodko, Madison Stoddard, Uyen Tran, Bruce Zetter, Michael Rogers, Bradley L. Pentelute, Jonathan M. Carlson, Mark Hixon, Diane Joseph-McCarthy, Arijit Chakravarty
medRxiv 2020.11.17.20233726; doi: https://doi.org/10.1101/2020.11.17.20233726
Risk of evolutionary escape from neutralizing antibodies targeting SARS-CoV-2 spike protein
Debra Van Egeren, Alexander Novokhodko, Madison Stoddard, Uyen Tran, Bruce Zetter, Michael Rogers, Bradley L. Pentelute, Jonathan M. Carlson, Mark Hixon, Diane Joseph-McCarthy, Arijit Chakravarty
medRxiv 2020.11.17.20233726; doi: https://doi.org/10.1101/2020.11.17.20233726
Subject Area
Subject Areas
- Addiction Medicine (339)
- Allergy and Immunology (665)
- Anesthesia (179)
- Cardiovascular Medicine (2620)
- Dermatology (220)
- Emergency Medicine (396)
- Epidemiology (12160)
- Forensic Medicine (10)
- Gastroenterology (754)
- Genetic and Genomic Medicine (4049)
- Geriatric Medicine (383)
- Health Economics (674)
- Health Informatics (2616)
- Health Policy (996)
- Hematology (359)
- HIV/AIDS (837)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (429)
- Neurology (3820)
- Nursing (208)
- Nutrition (569)
- Oncology (2002)
- Ophthalmology (580)
- Orthopedics (238)
- Otolaryngology (303)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (470)
- Pediatrics (1106)
- Primary Care Research (444)
- Public and Global Health (6491)
- Radiology and Imaging (1383)
- Respiratory Medicine (868)
- Rheumatology (399)
- Sports Medicine (338)
- Surgery (440)
- Toxicology (52)
- Transplantation (185)
- Urology (165)